Vilon

Vilon, also called Lys‑Glu or the KE peptide, is a Khavinson dipeptide that researchers have examined for immune system modulation and cellular longevity, and the community primarily uses it to influence immune function. Users generally administer 1 mg per day; timing and cycling are rarely specified, with most posts omitting a schedule. The only clear limitation is that Vilon has no FDA‑approved indication, so any human use is off‑label or compounded, and injection‑site reactions have not emerged as a consistent theme in the limited reports.

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyno dataClinicalResearchSideEffectsno dataAnecdotalEfficacyAnecdotalSideEffectsPrice0.43.33.34.0

Measured on 4 of 6 axes

Research Evidence

Evidence shape

Vilon currently exists as an animal-only research peptide, with all available data restricted to preclinical and mechanistic studies. There are no published human trials or registered clinical studies for this compound, meaning its effects in human physiology remain unverified. Because the existing literature is limited to laboratory models, there is no evidence base to support its use for any specific indication in humans.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth17 rows captured
Human
direct clinical signal
0
Animal
translational support
12
In vitro
mechanistic support
5
HighMediumLow

Anecdotal efficacy

Vilon side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Price

Full buying guide →
1
prymalab.net
--
200 mg
$54.99
$0.27/mg
2
Cenexalabs
US
200 mg
$209.99
$1.05/mg
3
Peptides 4 Research
unknown
20 mg
$34.00
$1.7/mg
4
Rp Peptides
GB
20 mg
$36.24
$1.81/mg
5
Genesis Peptides
USA
20 mg
$39.00
$1.95/mg
6
Aminousa
US
20 mg
$40.00
$2/mg

price offers can be sorted by column

1-6 of 35

Vilon dosing & protocol

How Vilon is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
—
0
1 mg
2 mg
3 mg
4 mg
5 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance
Typical dose
—
0
1 mg
2 mg
3 mg
4 mg
5 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Anecdotal
Community-reported real-world use · n = 12
Typical dose
5 mg100 µg – 5 mg
typical
0
1 mg
2 mg
3 mg
4 mg
5 mg
distribution of 13 reported doses · darker = more
By reported cadence· tap a row to filter the chart
Frequency
daily
Route
subQ

Most users report dosing around 500 mcg (range 100 mcg–5 mg) without a set schedule, while a smaller group takes 5 mg daily (range 4–5 mg).

12 sources

Related peptides

PinealonCortagenThymogenBronchogenPancragenCardiogenCartalaxLivagenTestagenOvagenChonlutenProstamax